Category: Disease Prevention & Management

The Endocrine Society has officially named Lisa B. Nachtigall, MD, as the 2026 recipient of the Vigersky Outstanding Clinical Practitioner Award, a prestigious Laureate honor that recognizes physicians who have demonstrated exceptional commitment to patient care and the advancement of clinical endocrinology. As the Medical Director of the Mass General Brigham Pituitary Center and an…

Representative Kim Schrier (D-WA) has been officially designated as the incoming Democratic co-chair of the Congressional Diabetes Caucus, a pivotal leadership role within one of the largest and most influential bicameral organizations in the United States Congress. Representative Schrier is slated to succeed Representative Diana DeGette (D-CO), who will conclude her tenure in the House…

Women diagnosed with Polyendocrine Metabolic Ovarian Syndrome (PMOS), a condition formerly known as Polycystic Ovary Syndrome (PCOS), may face a heightened risk of developing Alzheimer’s disease and other forms of dementia later in life. A comprehensive review of existing medical literature, published in the Journal of the Endocrine Society, suggests that the cognitive decline associated…

Neuroendocrine neoplasms (NENs) represent a complex and heterogeneous group of tumors that originate from specialized cells of the neuroendocrine system, which are distributed throughout the human body. Because these cells serve as a bridge between the endocrine and nervous systems, the resulting neoplasms can manifest in virtually any organ, presenting a significant challenge for clinical…

The study, led by Marta Arajuo-Castro of the Hospital Universitario Ramon y Cajal in Madrid, Spain, and published in The Journal of Clinical Endocrinology & Metabolism, provides an international, retrospective analysis of 101 patients. The findings underscore a pivotal relationship: the physical size of the adrenal tumor and the biochemical severity of cortisol excess are…

The presence of endocrine-disrupting chemicals (EDCs) in both breast milk and the urine of infants from birth through the first six months of life has emerged as a significant public health concern, according to comprehensive research presented at ENDO 2026. The study, unveiled at the Endocrine Society’s annual meeting in Chicago, Illinois, provides a sobering…

Zerihun Haile-Selassie, CAE, the Chief Financial Officer of the Endocrine Society, has been formally recognized as a 2026 Nonprofit CFO of the Year, an honor that underscores his profound contributions to operational excellence, financial innovation, and organizational transparency. Haile-Selassie was selected as the winner in the category for Chief Financial Officers of large nonprofit associations,…

The landscape of endocrine and renal medicine underwent a significant shift this week as two major pharmaceutical developments reached critical milestones. Bayer announced that the U.S. Food and Drug Administration (FDA) has granted approval for KERENDIA (finerenone) as the first new treatment in three decades for adults with chronic kidney disease (CKD) associated with type…

The field of endocrinology is often likened to medical detective work, where clinicians must synthesize disparate biochemical markers and imaging findings to uncover complex physiological interactions. A remarkable case presented at the ENDO 2026 conference in Chicago has provided a vivid illustration of this dynamic, involving a 52-year-old male patient whose body was inadvertently treating…

This medical case, recently documented in the peer-reviewed journal JCEM Case Reports, provides a stark illustration of the complexities involved in diagnosing rare endocrine disorders and the potentially life-threatening consequences of clinical misinterpretation. Researchers in Brazil have detailed the harrowing medical journey of a 22-year-old man who, after living for two decades with undiagnosed congenital…